Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP12 pseudogene 2 (USP12P2) is a pseudogene annotated as related to the USP12 gene, which encodes Ubiquitin Specific Peptidase 12, a cysteine-type deubiquitinase enzyme involved in several cellular processes such as immune response, cell cycle regulation, and tumorigenesis. However, USP12P2 itself does not encode a functional enzyme or protein and is not known to participate in biological pathways, disease mechanisms, or therapeutic interventions. There is no evidence of USP12P2 acting as a receptor, enzyme, transporter, transcription factor, or other molecular target in human pathology or pharmacology. Accordingly, USP12P2 is not considered a therapeutic target. Curation caution: Ensure queries about USP12P2 are not conflated with USP12, which is an active protein-coding gene and valid therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on USP12 pseudogene 2 (USP12P2).